Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: The effect of atorvastatin treatment

Physiological Research

Volumn 57, Issue 2, 2008, Pages 185-194

  Stulc T ^a   Vrablik M ^a   Kasalova Z ^a   Marinov, I ^b   Svobodova H ^a   Ceska R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Atherosclerosis; Cell adhesion molecules; Cholesterol; Endothelium; Leukocytes

Indexed keywords

ATORVASTATIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PYRROLE DERIVATIVE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LEUKOCYTE; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; REFERENCE VALUE; STATISTICAL ANALYSIS;

ADULT; ANTICHOLESTEREMIC AGENTS; CELL ADHESION MOLECULES; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; LEUKOCYTES; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PYRROLES; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; VON WILLEBRAND FACTOR;

EID: 45849130235     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. DE BONT N, GEIJTENBEEK TB, NETEA MG, SMILDE TJ, DEMACKER PN, FIGDOR CG, VAN DER MEER JW, STALENHOEF AF: Integrin mediated adhesion of mononuclear cells from patients with familial hypercholesterolemia. Eur J Clin Invest 29: 749-757, 1999.
2. DIAMOND MS, SPRINGER TA: A subpopulation of MAC-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 120: 545-556, 1993.
3. FOLSOM AR, WU KK, ROSAMOND WD, SHARRETT AR, CHAMBLESS LE: Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Circulation 96: 1102-1108, 1997.
4. GALIS ZS, KHATRI JJ: Matrix metalloproteinases in vascular remodelling and atherogenesis. Circ Res 90: 251-262, 2002.
5. HANSSON GK, LIBBY P, SCHONBECK U, YAN ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91: 281-291, 2002.
6. HERNANDEZ C, LECUBE A, BARBERA G, CHACON P, LIMA J, SIMO R: Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men. Med Sci Monit 9: 114-119, 2003.
7. HUO Y, LEY K: Adhesion molecules and atherogenesis. Acta Physiol Scand 173: 35-43, 2001.
8. JONASSON L, HOLM J, SKALLI O, BONDJERS G, HANSSON GK: Regional accumulation of T-cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138, 1986.
9. JORDAN JE, ZHAO ZQ, JOHANSEN JV: The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
10. KASSIRER M, ZELTSER D, PROCHOROV V, SCHOENMAN G, FRIMERMAN A, KEREN G, SHAPIRA I, MILLER H, ROTH A, ARBER N, ELDOR A, BERLINER S: Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: Further evidence for smoldering inflammation in patients with atherosclerosis. Am Heart J 138: 555-559, 1999.
11. KAWAKAMI A, TANAKA A, NAKAJIMA K, SHIMOKADO K, YOSHIDA M: Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res 91: 263-271, 2002.
12. KOWALSKI J, OKOPIEN B, MADEJ A, ZIELINSKI M, BELOWSKI D, KALINA Z, HERMAN ZS: Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. Int J Clin Pharmacol Ther 41: 241-247, 2003.
13. KRIEGLSTEIN CF, GRANGER DN: Adhesion molecules and their role in vascular disease. Am J Hypertens 14: 44S-54S, 2001.
14. LEHR HA, KROMBACH F, MUNZING S, BODLAJ R, GLAUBITT SI, SEIFFGE D, HUBNER C, VON ANDRIAN UH, MESSMER K: In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 146: 218-227, 1995.
15. LI D, CHEN H, ROMEO F, SAWAMURA T, SALDEEN T, MEHTA JL: Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther 302: 601-605, 2002.
16. MAZZONE A, DE SERVI S, MAZZUCCHELLI I, FOSSATI G, GRITTI D, CANALE C, CUSA C, RICEVUTI G: Increased expression of CD11b/CD18 on phagocytes in ischemic disease: a bridge between inflammation and coagulation. Eur J Clin Invest 27: 648-652, 1997.
17. MCGORISK GM, TREASURE CB: Endothelial dysfunction in coronary heart disease. Curr Opin Cardiol 11: 341-350, 1996.
18. MEERSCHAERT JA, FURIE MB: The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 no monocytes and ICA-1, VCAM-1, and other ligands on endothelium. J Immunol 154: 4099-4112, 1995.
19. RAGAB MS, SELVARAJ P, SGOUTAS DS: Oxidized lipoprotein(a) induces cell adhesion molecule MAC-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. Atherosclerosis 123: 103-113, 1996.
20. REZAIE-MAJD A, PRAGER GW, BUCEK RA, SCHERNTHANER GH, MACA T, KRESS HG, VALENT P, BINDER BR, MINAR E, BAGHESTANIAN M: Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 23: 397-403, 2003.
21. RODRIGUEZ-FERNANDEZ JL, SANCHEZ-MARTIN L, REY M, VINCENTE-MAZANARES M, NARUMIYA S, TEXIDO J, SANCHEZ-MADRID F, CABANAS C: Rho and Rho-associated kinase modulate the tyrosine kinase PYK2 in T-cells through regulation of the activity of the integrin LFA-1. J Biol Chem 276: 40518-40527, 2001.
22. ROSENFELD ME: Leukocyte recruitment into developing atherosclerotic lesions. Arterioscler Thromb Vasc Biol 22: 361-363, 2002.
23. ROSENSON RS, WOLFF D, TANGNEY CC: Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolemia. Clin Sci (Lond) 106: 215-217, 2004.
24. ROVERS C, NETEA MG, DE BONT N, DEMACKER PNM, JACOBS C, KULLBERG BJ, VAN DER MEER JWM, STALENHOEF AFH: LPS-induced cytokine production and expression of β2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia. Atherosclerosis 141: 99-105, 1998.
25. RUGGERI ZM, WARE J: The structure and function of von Willebrand factor. Thromb Haemost 67: 594-599, 1992.
26. SBAROUNI E, KROUPIS C, KYRIAKIDES ZS, KONIAVITOU K, KREMASTINOS DT: Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease. Eur Heart J 21: 975-980, 2000.
27. SEMAAN HB, GURBEL PA, ANDERSON JL, MUHLESTEIN JB, CARLQUIST JF, HORNE BD, SEREBRUANY VL: Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. Cardiology 93: 7-10, 2000.
28. SERRANO CV JR, YOSHIDA VM, VENTURINELLI ML, D'AMICO E, MONTEIRO HP, RAMIRES JA, DA LUZ PL: Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia. Atherosclerosis 157: 505-512, 2001.
29. UNO H, UEKI Y, MURASHIMA J, MIYAKE S, TOMINAGA Y, EGUCHI K, YANO K: Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance. Atherosclerosis 116: 93-102, 1995.
30. VAN DER WAL AC, BECKER AE, VAN DER LOOS CM, DAS PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44, 1994.
31. WANG Y, BLESSING F, WALLI AK, UBERFUHR P, FRAUNBERGER P, SEIDEL D: Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins: reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 175: 145-150, 2004.
32. WAUTIER JL, SCHMID-SCHONBEIN GW, NASH GB: Measurement of leukocyte rheology in vascular disease: clinical rationale and methodology. Clin Hemorheol Microcirc 21: 7-24, 1999.
33. WEBER C, ERL W, WEBER KSC, WEBER PC: HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 30: 1212-1217, 1997.
34. YUAN Y, VERNA LK, WANG NP, LIAO HL, MA KS, WANG Y, ZHU Y, STEMERMAN MB: Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim Biophys Acta 1534: 139-148, 2001.